Stockscreener 앱 받기
41.53
1.79%
0.73
시간 외 거래:
41.25
-0.28
-0.67%
전일 마감가:
$40.80
열려 있는:
$41.34
하루 거래량:
444.66K
Relative Volume:
0.69
시가총액:
$1.86B
수익:
$1.15B
순이익/손실:
$23.09M
주가수익비율:
83.06
EPS:
0.5
순현금흐름:
$89.18M
1주 성능:
+0.39%
1개월 성능:
-11.05%
6개월 성능:
+25.39%
1년 성능:
+11.07%
1일 변동 폭
$40.99
$41.95
1주일 범위
$39.97
$42.60
52주 변동 폭
$22.66
$55.00
옴니셀 Stock (OMCL) Company Profile
명칭
Omnicell Inc
전화
(877) 415-9990
주소
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, TEM, BTSG, HQY, WAY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
41.53 | 1.83B | 1.15B | 23.09M | 89.18M | 0.50 |
|
VEEV
Veeva Systems Inc
|
188.48 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
51.29 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.96 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
81.15 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.93 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
옴니셀 Stock (OMCL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2026-01-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-05-14 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-08-02 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-01-03 | 개시 | Barclays | Underweight |
| 2023-11-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-11-03 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | 재확인 | Wells Fargo | Underweight |
| 2023-08-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2022-11-03 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | 개시 | BofA Securities | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Mkt Perform |
| 2021-12-06 | 재개 | Wells Fargo | Overweight |
| 2021-06-09 | 개시 | JP Morgan | Neutral |
| 2021-05-24 | 개시 | BTIG Research | Buy |
| 2021-02-02 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | 개시 | Berenberg | Buy |
| 2020-12-03 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | 개시 | Stephens | Overweight |
| 2020-02-07 | 재확인 | Dougherty & Company | Buy |
| 2019-11-21 | 재확인 | Dougherty & Company | Buy |
| 2019-07-26 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2019-03-07 | 재확인 | Dougherty & Company | Buy |
| 2018-06-29 | 재개 | The Benchmark Company | Buy |
| 2017-09-05 | 재확인 | The Benchmark Company | Buy |
| 2017-07-28 | 재확인 | Dougherty & Company | Buy |
| 2017-04-21 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | 개시 | Dougherty & Company | Buy |
| 2016-12-06 | 재확인 | The Benchmark Company | Buy |
| 2016-07-07 | 재확인 | FBR Capital | Outperform |
| 2016-03-21 | 재확인 | Topeka Capital Markets | Buy |
| 2016-01-07 | 개시 | The Benchmark Company | Buy |
| 2015-11-16 | 재확인 | Topeka Capital Markets | Buy |
| 2015-10-30 | 재확인 | FBR Capital | Outperform |
| 2015-09-28 | 업그레이드 | Sidoti | Neutral → Buy |
| 2015-07-31 | 재확인 | Topeka Capital Markets | Buy |
모두보기
옴니셀 주식(OMCL)의 최신 뉴스
Omnicell, Inc. $OMCL Shares Sold by JPMorgan Chase & Co. - MarketBeat
Omnicell Stock Analysis: Strong Performance vs. Long-Term ConcernsNews and Statistics - IndexBox
OMCL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Omnicell, Inc. (OMCL) Stock Analysis: Strong Buy Ratings And Nearly 40% Upside Potential - DirectorsTalk Interviews
Vanguard Group Inc. Has $170.89 Million Holdings in Omnicell, Inc. $OMCL - MarketBeat
Roubaix Capital LLC Purchases Shares of 76,383 Omnicell, Inc. $OMCL - MarketBeat
3 Reasons to Avoid OMCL and 1 Stock to Buy Instead - Finviz
What is Zacks Research's Estimate for Omnicell Q1 Earnings? - MarketBeat
Dividend Watch: Whats the fair value of Omnicell Inc stockEarnings Overview Summary & Verified Momentum Stock Watchlist - baoquankhu1.vn
Omnicell, Inc. (OMCL): A Bull Case Theory - Yahoo Finance
Should Omnicell’s Shift Toward Software and Services Require Action From Omnicell (OMCL) Investors? - Sahm
OMCL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
What is Zacks Research's Estimate for Omnicell Q3 Earnings? - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Decoding Omnicell Inc (OMCL): A Strategic SWOT Insight - GuruFocus
(OMCL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Omnicell, Inc. (OMCL) Investor Outlook: Examining a 45% Potential Upside Amid Healthcare Innovation - DirectorsTalk Interviews
Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know - Finviz
Healthcare Inventory Management Market Hits New High | Major - openPR.com
Omnicell Inc (OMCL) Trading 3.26% Higher on Feb 20 - GuruFocus
Omnicell (OMCL) VP reports tax withholding and ESPP share purchase - Stock Titan
Omnicell (OMCL) insider plans Rule 144 sale of 4,243 vested shares - Stock Titan
Hospital Robotics (Logistics and Pharmacy) Market to Reach USD - openPR.com
Does Omnicell’s Profit Squeeze Amid Higher Sales and 2026 Outlook Change The Bull Case For OMCL? - simplywall.st
Merger Talk: Is NewAmsterdam Pharma Company NVs ROIC above industry average2025 Technical Overview & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Omnicell, Inc. (NASDAQ:OMCL) Sees Large Drop in Short Interest - MarketBeat
Responsive Playbooks and the OMCL Inflection - Stock Traders Daily
Growth Report: How volatile is Omnicell Inc stock2025 Price Momentum & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Reasons to add Omnicell stock to your portfolio right now - MSN
Smart Medicine Compounding Robot Market Is Going to Boom | ARxIUM - openPR.com
Omnicell (OMCL) Is Down 19.0% After Profit Squeeze Despite Solid 2026 Revenue OutlookWhat's Changed - Yahoo Finance
Little Excitement Around Omnicell, Inc.'s (NASDAQ:OMCL) Revenues As Shares Take 26% Pounding - 富途牛牛
Why Investors Shouldn't Be Surprised By Omnicell, Inc.'s (NASDAQ:OMCL) 26% Share Price Plunge - simplywall.st
The Top 5 Analyst Questions From Omnicell's Q4 Earnings Call - Finviz
The Top 5 Analyst Questions From Omnicell’s Q4 Earnings Call - Yahoo Finance
Omnicell (NASDAQ:OMCL) Cut to Strong Sell at Zacks Research - MarketBeat
Omnicell, Inc. (OMCL) Stock Analysis: Unpacking a Potential 57% Upside in Healthcare Automation - DirectorsTalk Interviews
Omnicell (OMCL) Q4 2025 Earnings Call Transcript - AOL.com
Omnicell: Solid Execution and Strategic Promise Offset by Near-Term Profitability Pressures and Premium Valuation (Hold Rating Maintained) - TipRanks
Omnicell, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:OMCL) 2026-02-08 - Seeking Alpha
Omnicell upgraded at BofA on buying opportunity ahead of Q4 results - MSN
Omnicell (OMCL) Margin Squeeze To 0.2% Net Profit Tests Bullish Recovery Narratives - Sahm
Analysts Conflicted on These Healthcare Names: Cigna (CI), Hims & Hers Health (HIMS) and Omnicell (OMCL) - The Globe and Mail
Omnicell (NASDAQ:OMCL) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
Omnicell Earnings Call: Growth Intact, Margins Under Strain - The Globe and Mail
Omnicell, Inc. (NASDAQ:OMCL) Q4 2025 Earnings Call Transcript - Insider Monkey
Omnicell (NASDAQ:OMCL) Stock Price Down 4.2% on Disappointing Earnings - MarketBeat
Analyst Jessica Tassan Lowers Omnicell (OMCL) Price Target to $4 - GuruFocus
Omnicell Q4 2025 Earnings: Stock Dives on Missed EPS, 2026 GuidanceNews and Statistics - IndexBox
Omnicell Stock Pre-Market (-15%) : Q4 EPS Miss & Weak 2026 Guidance - Trefis
Pharmacy Automation Systems Market Set for Explosive Growth - openPR.com
옴니셀 (OMCL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.25%
1.11%
자본화:
|
볼륨(24시간):